Frontlight ResearchEarly access
Type 2 diabetes trials in United States
348 of 392 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleA Study Evaluating the Safety of Inavolisib and Fulvestrant With or Without Palbociclib in Participants With Advanced Breast Cancer (ABC) and Type 2 Diabetes
- Where
- Atlanta, Clovis, Germantown, Grand Island, Mineola, Morgantown, New York, Omaha, Torrance, Washington D.C.
- Age
- 18 years and over
- People
- 40 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07748208 - Phase 3Taking peopleA Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
- Where
- Albuquerque, Austin, Beaver, Birmingham, Blackfoot, Bluffton, Brooklyn, Brownsville, Buckley, Canoga Park, Canton, Chattanooga, City of Saint Peters, Clearwater, Columbus, Concord, Conroe, Dallas, Dearborn, Escondido, Fayetteville, Fleming Island, Fort Myers, Georgetown, Gilbert, Greensboro, Hollywood, Honolulu, Houston, Idaho Falls, Jacksonville, Kalispell, Kenosha, Lakeland, Largo, Las Vegas, Lawrenceville, Lexington, Lincoln, Little Rock, Long Beach, Maumee, Memphis, Meridian, Mesquite, Miami, Minneapolis, Miramar, Missoula, Morehead City, Newport News, Norco, Northridge, Oklahoma City, Olive Branch, Oxnard, Paradise Valley, Peoria, Phoenix, Pittsburgh, Redmond, Ridgeland, Riverview, Rockville, Salt Lake City, San Antonio, San Diego, Shavano Park, Skokie, Spartanburg, Spring Valley, Topeka, Troy, Tustin, Union City, Uniontown, University Park, Wadsworth, Walnut Creek, Weslaco, West Hills, Weston, West Palm Beach, Winter Park
- Age
- 18 years and over
- People
- 600 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07754461 - No phaseTaking peopleEvaluation of MiniMed Next Generation Extended Wear Sensors and Algorithm in Patients With Type 1 and Type 2 Diabetes
- Where
- Atlanta, Aurora, Austin, Charlottesville, Chula Vista, Escondido, Gainesville, Idaho Falls, New Haven, Palo Alto, Renton, San Antonio, San Diego, San Francisco, Santa Barbara, Seattle, Tampa, Walnut Creek
- Age
- 2 years to 80 years
- People
- 1,500
- Run by
- Medtronic MiniMed, Inc.
See details and how to joinNCT07864168 - No phaseTaking peopleFood Insecurity Reduction & Strategy Team
- Where
- Palo Alto
- Age
- 18 years and over
- People
- 160
- Run by
- Stanford University
See details and how to joinNCT06329375 - Phase 1Taking peopleA Study to Investigate Safety, Tolerability, PK, and PD of AZD4248 in Healthy Participants, Participants With CKD and Type 2 Diabetes, Assess Home Measurements of Creatinine in a Non-Interventional Cohort, and Assess the Effect of AZD4248 on the PK of Midazolam and Metformin in Healthy Participants
- Where
- Ann Arbor, Chicago, Glendale, Saint Paul, San Antonio
- Age
- 18 years to 75 years
- People
- 192
- Run by
- AstraZeneca
See details and how to joinNCT07024823 - Phase 3Taking peopleEASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Where
- Albany, Albuquerque, Anniston, Aurora, Austin, Avon, Baltimore, Beaver, Beverly Hills, Billings, Binghamton, Boca Raton, Bossier City, Bowling Green, Bridgeport, Bridgewater, Brownsville, Buffalo, Camp Hill, Canoga Park, Cary, Chandler, Chapel Hill, Chicago, Cincinnati, Clearwater, Columbus, Concord, Covington, Cutler Bay, Dakota Dunes, Dallas, Dearborn, DeLand, Doral, El Dorado, Elkhart, El Paso, Fairhope, Falls Church, Fargo, Fayette, Fleming Island, Flint, Forney, Fort Mill, Fort Myers, Fort Worth, Franklin, Fremont, Gaffney, Golden, Greenfield, Greenville, Guntersville, Hallandale, Hamden, Honolulu, Houston, Huntington Park, Idaho Falls, Jacksonville, Jefferson City, Johns Creek, Kansas City, Kenosha, Kissimmee, Knoxville, Lake City, Lakeland, La Mesa, Lancaster, Las Vegas, Lenoir, Lewisville, Lexington, Linden, Lombard, Long Beach, Macon, Malden, Manassas, Marietta, Mesquite, Methuen, Miami, Miami Lakes, Monroe, Mooresville, Morehead City, Morgantown, Muncie, Naples, New Port Richey, New York, Norfolk, North Las Vegas, Oak Lawn, Oklahoma City, Olney, Omaha, Orange, Orlando, Ormond Beach, Owensboro, Oxon Hill, Palm Beach Gardens, Palmetto Bay, Pembroke Pines, Philadelphia, Phoenix, Pittsburgh, Pomona, Port Charlotte, Richmond, Riverhead, Riverview, Rochester, Saint Augustine, Salisbury, Salt Lake City, San Antonio, San Bernardino, San Diego, San Marcos, Santa Rosa, Saratoga Springs, Savannah, Scottdale, Shavano Park, Sherman, Shreveport, Slidell, Smithfield, Somerset, Stamford, Stephenville, St Louis, St. Petersburg, Sun City West, Tacoma, Tempe, Thomasville, Tomball, Topeka, Torrance, Troy, Tucker, Tucson, Union, Uniontown, University Park, Vista, Waco, Wausau, Wauwatosa, Wellington, Weslaco, West Chester, Westfield, West Jordan, Westlake, West Monroe, West Seneca, Wichita, Wilmington, Winchester, Winston-Salem, Yardley, Yuma, Zachary
- Age
- 18 years and over
- People
- 11,800 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07064473 · EU 2025-521188-11-00 - Phase 2Taking peopleA Study to Compare Different Doses of Tifeglipron (RO7795081) With Placebo or Semaglutide in People With Type 2 Diabetes
- Where
- Austin, Bellaire, Butte, Cedarhurst, Clermont, Dallas, Knoxville, Lake Forest, Lima, Manassas, Nashville, Oak Lawn, Pembroke Pines, Philadelphia, Rancho Cucamonga, Spring Valley, Statesville, St. George, Tucson, Union City, Waco, Washington D.C., Waterbury, Wilmington
- Age
- 18 years and over
- People
- 330 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07112872 · EU 2024-520322-11-00 - Phase 3Not yet taking people in United StatesA Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes Treated With Diet and Exercise
- Where
- Boston, Fountain Valley, Hollywood, Houston, Los Angeles, Miami, Orlando, San Antonio, Spring Valley, Washington, Weston, Wilmington
- Age
- 18 years and over
- People
- 200 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07931495 · EU 2026-525470-18-00 - Phase 3Not yet taking people in United StatesA Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes and Chronic Kidney Disease Treated With Once Daily Basal Insulin Alone or in Combination With Metformin, SGLT2i, or Both
- Where
- Bristol, Brooklyn, Chapel Hill, Chattanooga, Fleming Island, Hollywood, Houston, Katy, La Jolla, Lancaster, Las Vegas, Lincoln, Miami, Morehead City, Mt. Dora, Nashville, Ocoee, Orlando, San Antonio, San Dimas, Shavano Park, Spartanburg, Tamarac, Weston
- Age
- 18 years and over
- People
- 450 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07931547 · EU 2026-525471-13-00 - Phase 3Not yet taking people in United StatesAMBITION 3: A Research Study Investigating How Well Zenagamtide at Higher Dose Levels Lowers Blood Sugar and Body Weight Compared to Semaglutide in People With Type 2 Diabetes Treated With Metformin, SGLT2i, or Both
- Where
- Albany, Boston, Bristol, Canton, Charleston, City of Saint Peters, Flint, Greensboro, Gurnee, Hollywood, Houston, Jacksonville, Katy, Kingsport, La Jolla, La Mesa, Lancaster, Las Vegas, Los Angeles, Meridian, Miami, Miami Gardens, Miramar, Monroe, Mt. Dora, Nashua, Nashville, Northridge, Ocoee, Olney, Orlando, Palm Springs, Phoenix, Renton, Rockville, San Antonio, San Diego, Sandy City, Santa Ana, Shavano Park, Sioux Falls, Spartanburg, Spring Valley, Tampa, Topeka, Walnut Creek, Waterbury, Weslaco, Weston, West Seneca, Wilmington
- Age
- 18 years and over
- People
- 1,200 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07931573 · EU 2026-525472-26-00 - Phase 3Not yet taking people in United StatesA Research Study Investigating How Well Zenagamtide at Lower Dose Levels Lowers Blood Sugar and Body Weight Compared to Semaglutide at Lower Dose Levels in People With Type 2 Diabetes Treated With Metformin, Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2i), or Both
- Where
- Albany, Aurora, Canton, Chesterfield, Chicago, City of Saint Peters, Conyers, Fleming Island, Flint, Greer, Hollywood, Houston, Jacksonville, Katy, Kingsport, La Jolla, Lancaster, Las Vegas, Lincoln, Miami, Mt. Dora, Nashua, Nashville, Newport News, Newton, Olney, Palm Springs, Rockville, San Antonio, Sandy City, Sioux Falls, Statesville, Tampa, West Des Moines, Westfield, Weston, West Seneca
- Age
- 18 years and over
- People
- 1,060 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07931599 · EU 2026-525474-20-00 - No phaseTaking peopleAdapting and Assessing the Feasibility of a Telehealth Diabetes Prevention Program for Hispanic Adolescents
- Where
- Houston
- Age
- 14 years to 16 years
- People
- 40
- Run by
- Baylor College of Medicine
See details and how to joinNCT06943001 - No phaseTaking peoplePATHS-UP Health Behavior Self-monitoring Mobile App for Adolescents
- Where
- Houston
- Age
- 12 years to 18 years
- People
- 30
- Run by
- Baylor College of Medicine
See details and how to joinNCT06959901 - No phaseTaking peopleContinuous Glucose Monitoring for Self-Management of Type 2 Diabetes in Young Adults
- Where
- San Diego
- Age
- 18 years to 45 years
- People
- 45
- Run by
- San Diego State University
See details and how to joinNCT07065721 - Phase 4Taking peoplePermissive Versus Strict Intrapartum Glucose Management in Type 1 and Type 2 Diabetes (PRISM)
- Where
- Columbus
- Age
- 18 years and over
- People
- 44
- Run by
- Ohio State University
See details and how to joinNCT07293715 - Phase 3Taking peopleA Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
- Where
- Anniston, Baltimore, Bellaire, Birmingham, Boston, Brownsville, Buffalo, Clarksville, Corpus Christi, Dallas, Dayton, Gulfport, Gurnee, Honolulu, Houston, Irvine, Louisville, McAllen, Milwaukee, Minneapolis, Myrtle Beach, Nashville, Needham, New Haven, New Orleans, Portland, Salt Lake City, San Antonio, San Diego, Schaumburg, Shavano Park, Sioux Falls, Skokie, Southlake, Springfield, Tucson, Tulsa, Union City, Walnut Creek, West Chester
- Age
- 18 years and over
- People
- 2,000 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07351045 · EU 2025-523104-71-00 - Phase 3Taking peopleA Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Where
- Blackfoot, Brownsville, Clearwater, Columbia, Columbus, Dallas, Decatur, Edinburg, Guntersville, Houston, Irvine, Kansas City, Lake Charles, Lake Forest, Long Beach, Manassas, Metairie, Montclair, Morehead City, New Orleans, Norco, Norman, North Charleston, Oklahoma City, Olive Branch, Pasadena, Pembroke Pines, Pittsburgh, Port Orange, Rancho Cucamonga, Redmond, San Antonio, Sioux Falls, Springfield, Spring Valley, St. Petersburg, Suffolk, Tomball, Tucson, Tulsa, Union City, Washington D.C., Winston-Salem
- Age
- 18 years and over
- People
- 1,600 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07351058 · EU 2025-523106-32-00 - Phase 3Taking peopleA Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
- Where
- Beltsville, Champaign, Chicago, Columbus, Escondido, Fargo, Franklin, Houston, Jacksonville, Kansas City, Las Vegas, Lincoln, Manassas, Oxon Hill, Portland, Renton, Smithfield, Somerset, Statesville, Stockbridge, Walnut Creek, Woodstock
- Age
- 18 years and over
- People
- 500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07776509 · EU 2025-523295-23-00 - Phase 3Taking peopleHome Self-administration of Maridebart Cafraglutide With Autoinjector in Adults Living With Obesity or Overweight
- Where
- Bowie, Chickasha, Columbus, Dallas, Denison, DeSoto, Greenville, Houston, Johns Creek, McKinney, Meridian, Miami, Morehead City, North Richland Hills, Oak Brook, Orlando, Rochester, San Diego, The Villages, Woodstock
- Age
- 18 years to 99 years
- People
- 230 worldwide
- Run by
- Amgen
See details and how to joinNCT07871409 - Phase 1/2Not yet taking people in United StatesRelacorilant in Patients With Poorly Controlled Type 2 Diabetes and Autonomous Cortisol Secretion
- Where
- San Antonio
- Age
- 18 years to 75 years
- People
- 34
- Run by
- The University of Texas Health Science Center at San Antonio
See details and how to joinNCT07925801 - No phaseTaking peopleLinking Education, Produce Provision, and Community Referrals to Improve Diabetes Care (LINK)
- Where
- Columbus
- Age
- 18 years and over
- People
- 568
- Run by
- Ohio State University
See details and how to joinNCT05472441 - No phaseTaking peopleUsing Ultromics EchoGo HFpEF Algorithm to Identify and Treat High Heart Failure Risk in Patients With Type 2 Diabetes
- Where
- Dallas
- People
- 800
- Run by
- University of Texas Southwestern Medical Center
See details and how to joinNCT06593314 - Early phase 1Enrolling by invitationTruway Diagnostic Tools in Primary Care
- Where
- New York
- People
- 200
- Run by
- Truway Health, Inc.
See details and how to joinNCT07209527 - Phase 3Taking peopleA Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- Where
- Albuquerque, Baltimore, Canoga Park, Chicago, Cincinnati, Crystal River, Escondido, Evanston, Evansville, Flint, Greensboro, Houston, Lecanto, Louisville, Miramar, Modesto, New Port Richey, New York, Norfolk, Omaha, Pembroke Pines, Rochester, Sacramento, San Antonio, Skokie, Tustin, Walnut Creek, West Hills, Wilmington
- Age
- 18 years and over
- People
- 954 worldwide
- Run by
- Pfizer
See details and how to joinNCT07595549 · EU 2026-525318-75-00 - Phase 3Taking peopleA Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 Diabetes
- Where
- Ammon, Atlanta, Beaumont, Corpus Christi, Decatur, Edinburg, Nashville, Sacramento, San Diego, Shavano Park, Smithfield, Stamford, Syracuse, The Bronx, Topeka, Tulsa, Victoria
- Age
- 10 years to 17 years
- People
- 170 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07668336 · EU 2025-524811-35-00